Jun-Seok Seo
Vorsitzender bei CELLTRION HEALTHCARE CO., LTD.
Aktive Positionen von Jun-Seok Seo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CELLTRION HEALTHCARE CO., LTD. | Vorsitzender | - | - |
Celltrion Healthcare Holdings Co., Ltd.
 Celltrion Healthcare Holdings Co., Ltd. Financial ConglomeratesFinance Part of Celltrion Holdings Co., Ltd., Celltrion Healthcare Holdings Co., Ltd. operates as an investment holding South Korean company. The company is based in Inchon, South Korea. The company was founded in 2020. Heon-Young Yoo has been the CEO of the company since 2020. Celltrion Healthcare Holdings Co. was acquired by Celltrion Holdings Co., Ltd. on December 06, 2021. | Direktor/Vorstandsmitglied | 31.03.2021 | - |
Karriereverlauf von Jun-Seok Seo
Statistik
International
| Südkorea | 3 |
Operativ
| Director/Board Member | 1 |
| Chairman | 1 |
Sektoral
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Celltrion Healthcare Holdings Co., Ltd.
Celltrion Healthcare Holdings Co., Ltd. Financial ConglomeratesFinance Part of Celltrion Holdings Co., Ltd., Celltrion Healthcare Holdings Co., Ltd. operates as an investment holding South Korean company. The company is based in Inchon, South Korea. The company was founded in 2020. Heon-Young Yoo has been the CEO of the company since 2020. Celltrion Healthcare Holdings Co. was acquired by Celltrion Holdings Co., Ltd. on December 06, 2021. | Finance |
Celltrion Healthcare Co., Ltd.
 Celltrion Healthcare Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. Its products include infliximab, rituximab, and trastuzumab biosimilars. The company was founded on December 29, 1999 and is headquartered in Incheon, South Korea. | Health Technology |
- Börse
- Insiders
- Jun-Seok Seo
- Erfahrung